Why Meta and Google Reject Hemp Ads (and What Works Instead)

Hemp and CBD ads get rejected because Meta, Google, and LinkedIn classify hemp-derived products under their drug, supplement, or restricted-product policies. The platforms do not distinguish well between a compliant hemp business and a recreational cannabis brand, so automated review flags both. Appeals are slow, approvals are narrow, and accounts can be disabled for repeat rejections.

That is the short version. The rest of this post covers what each platform's policy actually says, why "compliant" ads still get pulled, and the channel that hemp and cannabis companies use when paid social is off the table.

What the platforms actually restrict

Policy language changes often. The names below are accurate to our last review. Confirm against the live policy page before you cite any of this to a client or a lawyer.

Meta (Facebook and Instagram)

Meta's rules live in the Meta Advertising Standards, under the Drugs and Pharmaceuticals section [VERIFY current section title]. Three things matter for hemp companies:

1. Recreational cannabis is prohibited. Ads that promote the sale or use of marijuana, THC products, or related paraphernalia are not allowed. No exceptions for state-legal markets.
2. Non-ingestible hemp and CBD products are restricted, not banned. Meta updated its policy in 2024 to allow topical CBD ads in the US, with conditions including written permission and, for some categories, LegitScript certification [VERIFY: date, certification requirement, and which product types qualify].
3. Ingestible CBD is the gray zone. Meta has moved toward allowing ingestible CBD ads for LegitScript-certified advertisers in the US [VERIFY current status]. Hemp seed products without cannabinoids (seed oil, hearts, fiber) sit in a different bucket and are generally allowed, but automated review does not always know that.

The practical result: even if your product qualifies, the word "hemp" in your ad copy, landing page, or business name triggers review. Approval is manual and can take days.

Google Ads

Google splits this across two policies. Dangerous Products or Services covers recreational drugs and prohibits ads for marijuana, THC products, and anything that "facilitates" their use [VERIFY policy wording]. Healthcare and Medicines covers supplements, and its Unapproved Pharmaceuticals and Supplements list is where most CBD products land [VERIFY].

Google loosened this in January 2023. Advertisers can run ads for topical CBD products with 0.3% THC or less in a limited set of US states, currently California, Colorado, and Puerto Rico, if they hold LegitScript certification [VERIFY state list and requirements]. Ingestible CBD is still not permitted. Hemp seed and hemp fiber products without cannabinoids are generally allowed, but Google's automated review disapproves them regularly under the drug policy, and the fix is a manual appeal.

LinkedIn

LinkedIn should be the natural home for hemp B2B advertising. It is not. The LinkedIn Advertising Policies prohibit ads for Illegal, Regulated, or Restricted Products, and the drug-related subsection includes cannabis and, in our experience, CBD products [VERIFY exact subsection name and whether CBD is named explicitly]. LinkedIn does not offer a LegitScript carve-out. Companies that get through usually do so by advertising a service (consulting, software, packaging) rather than a plant-derived product, and their landing pages get reviewed too.

Why "compliant" hemp ads still get pulled

Most hemp operators we talk to have done the work. Their products test under 0.3% THC. They make no health claims. They still get rejected. Here is why.

Automated review reads keywords, not COAs. The first pass on every platform is a classifier. It looks at ad text, images, landing page copy, and business name. "Hemp," "CBD," "cannabinoid," "full spectrum," and a picture of a leaf all score the same as a dispensary ad. Your lab results never enter the equation.

Landing pages count. An ad for hemp fiber insulation can be disapproved because the site's footer links to a CBD product line. Meta and Google review the destination, not just the creative.

Repeat rejections escalate. Three or four disapprovals in a short window can trigger an account restriction. On Meta this can mean losing the ad account, and sometimes the Business Manager, with a limited appeal path.

Certification is expensive and slow. LegitScript certification for CBD runs into the thousands of dollars per year, requires product-level documentation, and takes weeks [VERIFY current fee range]. It opens a narrow door (topicals, a few states) and does nothing for LinkedIn.

Policy moves faster than your media plan. A campaign that ran clean for six months can stop overnight when a classifier updates. You find out when spend drops to zero.

What this costs a hemp B2B company

Paid social is the default growth channel for most B2B companies. Take it away and a hemp wholesaler, extractor, or packaging supplier is left with trade shows, referrals, and organic search. Trade shows are two or three times a year. Referrals do not scale. Organic search works, but Google suppresses cannabis keyword data in Ads and the volume for hemp B2B terms is small. Search brings a trickle of high-intent visitors, not a pipeline.

So the real question is not "how do I get my ads approved." It is "which channel reaches hemp and cannabis buyers without asking a platform for permission."

What works instead: outbound

The channel the platforms cannot switch off is direct outreach. Cold email and LinkedIn messaging go straight to the buyer's inbox. No ad review, no classifier, no LegitScript. The only rules are the ones that govern all commercial email (CAN-SPAM in the US) and the ones your sending domains have to respect to stay out of spam.

For hemp and cannabis B2B, outbound has three specific advantages.

The buyer universe is small and findable. There are a finite number of licensed processors, wholesalers, brands, labs, and dispensary chains. State license databases, trade association rosters, and event exhibitor lists give you most of them. You do not need an algorithm to find your buyers. You need a list and a way to reach it.

Buyers already expect it. Hemp and cannabis B2B has always run on direct relationships. A well-written email from a supplier who understands the market is normal in this space in a way it is not in, say, enterprise software.

The economics are better than ads, even when ads work. A properly built cold email system sends a few thousand emails a month from warmed-up domains, at a fixed infrastructure cost. Reply rates in hemp B2B typically land between 2% and 6% when the list is tight and the copy is specific [VERIFY against current campaign data before publishing a number]. A meeting costs what it costs to build the list and write the sequence, not whatever the auction says that day.

What "done right" looks like

Outbound fails when it is treated as a cheap substitute for ads. Blasting a purchased list from your main domain gets you blacklisted and burns the domain your invoices go out on. The version that works has five parts.

1. Separate sending domains, warmed up for two to three weeks before the first real email.
2. A list built from real sources: license databases, association rosters, show exhibitors, verified against LinkedIn.
3. An ICP tight enough that the email can be specific. "Extractors in Oregon and Colorado running 500 kg/month or more" beats "cannabis companies."
4. Value before the ask. The first email sends something useful (a data point, a list, a sample) rather than a pitch. We call this the reverse lead magnet.
5. Reply handling and follow-up. Most meetings come from the third or fourth touch, and from a human answering replies within the hour.

That is the system behind our cannabis lead generation service. It is also the system laid out, step by step, in the playbook below if you want to build it in-house.

Outbound is not a workaround for hemp and cannabis companies. For this industry it is the primary channel. The ad platforms made that decision for you. The only choice left is whether you run outbound well or badly.